title: Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.
abstract: The mesolimbic dopamine system, which arises in the ventral tegmental area (VTA), is an important neural substrate for opiate reinforcement and addiction. Chronic exposure to opiates is known to produce biochemical adaptations in this brain region. We now show that these adaptations are associated with structural changes in VTA dopamine neurons. Individual VTA neurons in paraformaldehyde-fixed brain sections from control or morphine-treated rats were injected with the fluorescent dye Lucifer yellow. The identity of the injected cells as dopaminergic or nondopaminergic was determined by immunohistochemical labeling of the sections for tyrosine hydroxylase. Chronic morphine treatment resulted in a mean approximately 25% reduction in the area and perimeter of VTA dopamine neurons. This reduction in cell size was prevented by concomitant treatment of rats with naltrexone, an opioid receptor antagonist, as well as by intra-VTA infusion of brain-derived neurotrophic factor. In contrast, chronic morphine treatment did not alter the size of nondopaminergic neurons in the VTA, nor did it affect the total number of dopaminergic neurons in this brain region. The results of these studies provide direct evidence for structural alterations in VTA dopamine neurons as a consequence of chronic opiate exposure, which could contribute to changes in mesolimbic dopamine function associated with addiction.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
authors.forename: L
authors.initials: L
authors.lastname: Sklair-Tavron
authors.forename: W X
authors.initials: WX
authors.lastname: Shi
authors.forename: S B
authors.initials: SB
authors.lastname: Lane
authors.forename: H W
authors.initials: HW
authors.lastname: Harris
authors.forename: B S
authors.initials: BS
authors.lastname: Bunney
authors.forename: E J
authors.initials: EJ
authors.lastname: Nestler
mesh_terms: D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology*; D048429:Cell Size / Q000187:drug effects; D004298:Dopamine / Q000502:physiology*; D004334:Drug Administration Schedule; D009020:Morphine / Q000008:administration & dosage* / Q000494:pharmacology; D009021:Morphine Dependence / Q000473:pathology*; D009474:Neurons / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D017557:Ventral Tegmental Area / Q000187:drug effects*
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D009020:Morphine; D004298:Dopamine